SCHEMBL7459196

SCHEMBL7459196

N#Cc1cccc(C(=O)CC(=O)Nc2cc(-c3ccccn3)ccc2NC(=O)O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 2/20 0.48
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ALDH1A1 P00352 1/20 0.44
GSK3B P49841 1/20 0.41
GRM4 Q14833 1/20 0.41
SMO Q99835 1/20 0.41
GRM5 P41594 7/20 0.40
KDM4E B2RXH2 1/20 0.40
HTT P42858 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
VNN1 O95497 1/20 0.39
FFAR1 O14842 1/20 0.39
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CTSS P25774 1/20 0.39
HCAR2 Q8TDS4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5868972 0.86 MAPK14 (0.44) MAPK14NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL7459390 0.81 GSK3B (0.46) RAB9AGSK3BGRM5VNN1
SCHEMBL7065166 0.80 VCP (0.45) RAB9AGSK3BGRM5KAT6A
SCHEMBL7467152 0.80 ERCC5 (0.50) MAPK14NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL7465211 0.79 GSK3B (0.40) RAB9AALDH1A1GSK3BGRM5KDM4E
SCHEMBL7463263 0.78 GPR139 (0.45) RAB9AALDH1A1GSK3BGRM5VNN1
SCHEMBL7700583 0.77 GSK3B (0.43) NPC1RAB9ASMN1; SMN2ALDH1A1GSK3B
SCHEMBL5868787 0.75 HDAC1 (0.42) ALDH1A1GSK3BCTSBCTSS
SCHEMBL5869023 0.75 HDAC1 (0.42) ALDH1A1GSK3BCTSBCTSS
SCHEMBL5558039 0.73 NPC1 (0.39) MAPK14NPC1RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224175-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
WO-2001029012-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed